SCHEMBL4916249

SCHEMBL4916249

CN(C)CCN(C)C(=O)COc1ncc(Cl)cc1N

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
GAA P10253 2/20 0.36
GLA P06280 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
MAPT P10636 4/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19172529 0.85 ALDH1A1 (0.44) POLBALDH1A1KDM4EGAAGLA
SCHEMBL4906324 0.81 ALDH1A1 (0.39) HRH4POLBALDH1A1KDM4EGAA
SCHEMBL17293197 0.78 CHRNB2 (0.54) KDM4ECHRNB2CHRNA4MAPT
SCHEMBL4906310 0.73 CCR2 (0.57) CYP1A2CYP3A4CYP2C19
SCHEMBL17035201 0.72 MAPT (0.41) POLBALDH1A1KDM4EMAPTMEN1
SCHEMBL16438484 0.71 CYP1A2 (0.62) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL12988086 0.69 ALDH1A1 (0.49) ALDH1A1KDM4EGLAMAPTMEN1
SCHEMBL20795952 0.67 MAPT (0.39) POLBALDH1A1KDM4EGAAMAPT
SCHEMBL4911164 0.66 KDM4E (0.56) POLBALDH1A1KDM4EGAAGLA
SCHEMBL28592876 0.66 TSHR (0.34) MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
WO-2007067875-A2 PYRIDINYL SULFONAMIDE MODULATORS OF CHEMOKINE RECEPTORS GLAXO GROUP LIMTED (GB) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 HRH4 200/4885POLB 4267/4885ALDH1A1 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.